Literature DB >> 9794453

Plasma leptin turnover rates in lean and obese Zucker rats.

R Vilà1, C Adán, I Rafecas, J A Fernández-López, X Remesar, M Alemany.   

Abstract

Conscious female adult lean and obese Zucker rats were injected through the jugular vein with radioactive iodine-labeled murine leptin; in the ensuing 8 min, four blood samples were sequentially extracted from the carotid artery. The samples were used in a modified RIA for leptin, in which paired tubes received the same amount of either labeled or unlabeled leptin, thus allowing us to estimate both leptin levels and specific radioactivity. The data were used to determine the decay curve parameters from which the half-life of leptin (5.46 +/- 0.23 min for lean rats and 6.99 +/- 0.75 min for obese rats) as well as the size of its circulating pool (32 pmol/kg for lean rats and 267 pmol/kg for obese rats) and the overall degradation rate (96 fkat/kg for lean rats and 645 fkat/kg for obese rats) were estimated. These values are consistent with the hormonal role of leptin and the need for speedy changes in its levels in response to metabolic challenge.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794453     DOI: 10.1210/endo.139.11.6296

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Modulatory role of testosterone in plasma leptin turnover in rats.

Authors:  Daniel Castrogiovanni; Mario Perelló; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

2.  Rational Design of Dual Agonist-Antibody Fusions as Long-acting Therapeutic Hormones.

Authors:  Yan Liu; Ying Wang; Yong Zhang; Tao Liu; Haiqun Jia; Huafei Zou; Qiangwei Fu; Yuhan Zhang; Lucy Lu; Elizabeth Chao; Holly Parker; Van Nguyen-Tran; Weijun Shen; Danling Wang; Peter G Schultz; Feng Wang
Journal:  ACS Chem Biol       Date:  2016-10-05       Impact factor: 5.100

Review 3.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

Review 4.  Leptin in human physiology and therapeutics.

Authors:  Tina A Dardeno; Sharon H Chou; Hyun-Seuk Moon; John P Chamberland; Christina G Fiorenza; Christos S Mantzoros
Journal:  Front Neuroendocrinol       Date:  2010-06-17       Impact factor: 8.606

Review 5.  Comparative endocrinology of leptin: assessing function in a phylogenetic context.

Authors:  Richard L Londraville; Yazmin Macotela; Robert J Duff; Marietta R Easterling; Qin Liu; Erica J Crespi
Journal:  Gen Comp Endocrinol       Date:  2014-02-11       Impact factor: 2.822

6.  Transport across the blood-brain barrier of pluronic leptin.

Authors:  Tulin O Price; Susan A Farr; Xiang Yi; Serguei Vinogradov; Elena Batrakova; William A Banks; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

7.  PET imaging of leptin biodistribution and metabolism in rodents and primates.

Authors:  Giovanni Ceccarini; Robert R Flavell; Eduardo R Butelman; Michael Synan; Thomas E Willnow; Maya Bar-Dagan; Stanley J Goldsmith; Mary J Kreek; Paresh Kothari; Shankar Vallabhajosula; Tom W Muir; Jeffrey M Friedman
Journal:  Cell Metab       Date:  2009-08       Impact factor: 27.287

Review 8.  mTOR and regulation of energy homeostasis in humans.

Authors:  Marwan Mannaa; Stephanie Krämer; Michael Boschmann; Maik Gollasch
Journal:  J Mol Med (Berl)       Date:  2013-06-12       Impact factor: 4.599

9.  A meta-analysis of reference values of leptin concentration in healthy postmenopausal women.

Authors:  Xi Zhou; YanLan Chai; Ke Chen; YunYi Yang; Zi Liu
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.